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ATLL: a highly aggressive non-Hodgkin’s lymphoma of the patient’s own T-cells.
Aneuploidy: a condition in which premature separation of sister chromatids
results in the loss or gain of chromosomes in daughter cells. Aneuploidy
constitutes a prevalent form of genetic instability observed in many types of
human cancer.
Blinkin: a human protein that acts as a central component of the Knl1–Mis12–
Ndc80 (KMN) network. In humans it is also referred to as KNL1, CASC5 and
AF15Q14; known as KNL-1 in worms, Spc105 in yeast and Spc105R in flies.
CENP-E: a member of the kinesin motor protein family that accumulates in the
G2 phase of the cell cycle and first appears at the centromere region of
chromosomes during prometaphase.
CENP-F: a protein that associates with the centromere–kinetochore complex
during mitosis. This protein maintains its association with the kinetochore
throughout early anaphase and binds CENP-E and BUB1, thus suggesting a
role in chromosome segregation and/or the mitotic checkpoint.
Knl1–Mis12–Ndc80 (KMN) network: A conserved assembly consisting of
Knl1, the Mis12 complex, and the Ndc80 complex that constitutes the core
attachment site for microtubules at the kinetochore and recruits components
that generate the mitotic checkpoint signal. The Mis12 complex is formed by
the proteins Mis12, Dsn1, Nnf1 and Nsl1 whereas the Ndc80 complex is formed
by Ndc80, Nuf2, Spc24 and Spc25.
Paralog: homologous sequences that are the result of a gene duplication event
and have descended side by side during the history of an organism.
P+1 loop: a small motif, residing immediately downstream of the activation
loop of a kinase domain. The P+1 loop received its named for its role in
contacting the residue immediately C-terminal to the phosphorylated tyrosine
(the P+1 position of the residue) in the substrate. The P+1 loop is implicated in
recognizing the residues next to tyrosine to be phosphorylated in the substrate.
TPR motif: a protein motif defined by a helix–loop–helix, in which the
consensus 34 amino acids sequence contains small hydrophobic residues at
positions 8, 20 and 27; large hydrophobic residues at positions 4, 7, 11 and 24;The multidomain protein kinases BUB1 and BUBR1
(Mad3 in yeast, worms and plants) are central compo-
nents of the mitotic checkpoint for spindle assembly
(SAC). This evolutionarily conserved and essential self-
monitoring system of the eukaryotic cell cycle ensures
the high fidelity of chromosome segregation by delaying
the onset of anaphase until all chromosomes are prop-
erly bi-oriented on the mitotic spindle. Despite their
amino acid sequence conservation and similar domain
organization, BUB1 and BUBR1 perform different func-
tions in the SAC. Recent structural information provides
crucial molecular insights into the regulation and recog-
nition of BUB1 and BUBR1, and a solid foundation to
dissect the roles of these proteins in the control of
chromosome segregation in normal and oncogenic cells.
BUB1 and BUBR1 are versatile proteins
The missegregation of sister chromatids during mitosis
results in aneuploidy; the loss or gain of chromosomes in
daughter cells. This disastrous outcome is avoided by the
mitotic checkpoint for spindle assembly, also known as the
spindle assembly checkpoint (SAC) (Box 1). BUB1 (bud-
ding uninhibited by benzimidazole 1) andBUBR1 (budding
uninhibited by benzimidazole-related 1) also called
BUB1B, and known as Mad3 (for mitotic-arrest deficient)
in yeast, worms and plants) play central roles in this
process. Three main regions can be identified in BUB1
and BUBR1 (two in Mad3): a conserved N-terminal region
that contains the kinetochore localization domain; an in-
termediate, non-conserved region that is required for
BUB3 binding; and a C-terminal region that contains a
catalytic serine/threonine kinase domain (Figure 1). The
BUBR1 homolog Mad3 lacks the C-terminal catalytic do-
main. However, there are no known species with both
BUBR1 and Mad3; therefore, the functions fulfilled by
BUBR1 in mammals probably are carried out by Mad3
in yeast, worms and plants.
Although they share a similar domain organization,
BUB1 and BUBR1 (Mad3) are paralogs, and have distinct
roles in the SAC. On the one hand, BUB1 is required for
chromosome congression, kinetochore localization of
MAD2, BUBR1 and centromere-associated protein
(CENP)-E and CENP-F in cells with an unsatisfied mitotic
checkpoint, and for the establishment and/or maintenance
of efficient bipolar attachment to spindle microtubules
[1–3]. Deletion of bub1 from Schizosaccharomyces pombe
increases the rate of chromosome missegregation [4],
whereas deletion of BUB1 from Saccharomyces cerevisiaeCorresponding author: Bolanos-Garcia, V.M. (victor@cryst.bioc.cam.ac.uk).
0968-0004 2010 Elsevier Ltd. All rights reserved. doi:10.1016/j.tibs.2010.08.004results in slow growth and elevated chromosome loss [5].
On the other hand, BUBR1 associates with unattached/
incorrectly attached kinetochores and plays roles in stabi-
lizing kinetochore–microtubule attachment and in chromo-
some alignment [2]. BUBR1 forms part of the mitotic
checkpoint complex (MCC) that also contains BUB3,
MAD2 and cell division cycle 20 (CDC20), and inhibits
the anaphase-promoting complex or cyclosome (APC/C) E3
ubiquitin ligase activity towards cyclin B1 and securin.
Although there is considerable debate regarding the role of
CDC20 ubiquitylation in the SAC (one model suggests that
CDC20 ubiquitylation silences the SAC, whereas another
suggests it exerts the SAC by degrading CDC20) [6,7], the
mechanism of APC/C–CDC20 inhibition by theMCCpoints
to a role for BUBR1 (Mad3) as a pseudo-substrate inhibi-
tor. Moreover, BUBR1 regulates prophase I arrest, which
is important for the progression through meiosis I to
produce fertilizable eggs [8], and also accumulates to acen-
tric chromatids that result from unrepaired DNA double-
strand breaks [9].
Here, we review what is known of the domain organi-
zation and functions of the central mitotic checkpointand one a-helix-breaking residue, typically a proline, at position 32.
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Box 1. The mitotic SAC
The function of this self-monitoring mechanism can be summarized as
follows: in prometaphase, the nuclear envelope breaks down and
microtubules that emanate from opposite poles attach to the kineto-
chores of individual sister chromatids. Cells with an unsatisfied
checkpoint recruit BUB1, BUBR1, BUB3, MAD1, MAD2 and CDC20 to
unattached kinetochores (Figure I). MAD1 forms a stable complex with
MAD2 in vitro. An inactive open-MAD2 conformation is catalytically
converted to a closed-MAD2 conformation that is able to bind to CDC20.
The MAD2–CDC20 association prevents loss of cohesion on bi-oriented
sister chromatids because it triggers the recruitment of BUBR1–BUB3
into an APC/C inhibitory complex. BUBR1 association with BUB3,
MAD2, and CDC20 is referred as the MCC, which interacts with the
APC/C to render it inactive (Figure I). The function of the SAC is linked to
the kinetochore–microtubule network through the physical interaction
of BUB1 and BUBR1 with blinkin; this interaction is required for
directing BUB1 and BUBR1 to the kinetochores. In metaphase,
the checkpoint is satisfied (i.e. all chromosomes undergo bipolar
attachment and are aligned at the center of the cell), which releases
APC/C–CDC20 inhibition. This is followed by the onset of anaphase, in
which sister chromatids separate and are pulled toward opposite poles
of the cell. When the checkpoint is satisfied, securin can be
ubiquitylated by APC/C and degraded. This leads to the release and
activation of separase, a caspase-like protease that cleaves cohesin, the
molecule that holds sister chromatids together at the centromere. The
cleavage of mitotic cohesin at centromeres and chromosome arms is
followed by chromosome separation and mitotic progression from
M-phase to interphase. Mitotic exit is achieved by destruction of cyclin
B1, which leads to inactivation of CDK1. This is followed by
disassembly of the spindle, decondensation of chromosomes and
re-assembly of the nuclear envelope.
[(Box_1)TD$FIG]
Figure I. Simplified model of BUB1 and BUBR1 functions in the SAC.
Review Trends in Biochemical Sciences March 2011, Vol. 36, No. 3proteins BUB1 and BUBR1. We discuss the emerging
evidence concerning 3D structures of the constituent
domains and the contribution of such structural informa-
tion for the molecular understanding of the roles of BUB1
and BUBR1 in the SAC. We also describe the mapping of
cancer-associated and chromosome-segregation-deficient
BUB1 and BUBR1 mutations onto existing structures.
Finally, we consider how the structural characterization
of higher-order complexes might provide further insights142into the functional mechanism and regulation of the SAC
signaling system as a whole.
Functional insights from structural information
Considerable advances have been made in the structural
biology of individual components and complexes of the SAC
signaling pathway, including Mad2 (PDB codes: 1DUJ,
1KLQ, 1S2H, 2V64 and 2VFX), the Mad1–Mad2 core com-
plex (1GO4), Mad2–p31(comet) (2QYF), Bub3 (1YFQ and
[(Figure_1)TD$FIG]
Figure 1. Domain organization of BUB1, BUBR1 and Mad3. The main functions associated with different domains are highlighted. The conserved functional motifs KEN,
GLEBS and regions of low structural complexity (LCR) are indicated. Mad3 is a BUBR1 homolog that lacks the catalytic serine/threonine kinase domain.
Review Trends in Biochemical Sciences March 2011, Vol. 36, No. 31U4C), Bub1 and Mad3 peptides mimicking the Gle2-
binding-sequence (GLEBS) motif in complex with Bub3
(2I3S and 2I3T, respectively), as well as individual BUB1
and BUBR1 domains (Table 1).
N-terminal region
The N-terminal domain, the most conserved region in both
BUB1 and BUBR1 and their homologs [10], is essential for
an efficient SAC [4]. Studies conducted in Bub1 mutant
murine embryonic fibroblasts have shown that deletion of
two exons that encode a large part of the conserved
N-terminal region leads to chromosome segregation errors,
increased chromosome instability, and an attenuated spin-
dle checkpoint response, thus confirming the importance of
this region for BUB1 function [11]. Moreover, the N-termi-
nal region mediates the physical contact of BUB1 and
BUBR1 with blinkin. These interactions are important
for the kinetochore localization of BUB1 and BUBR1
[12]. Furthermore, kinetochore-bound BUB1 is required
for the recruitment of CENP-F, shugoshin (SGO1), and
BUBR1 to kinetochores in cells with an unsatisfied mitotic
checkpoint [13]. The crystal structures of the N-terminal
regions of yeast Bub1 and human BUBR1, which are
essential for binding blinkin, reveal a common fold that
comprises a triple-tandem arrangement of the tetratrico-
peptide repeat (TPR) motif (Figure 2A) [14,15]. The TPR
regions of human peroxin-5 (PEX5), heat shock protein 90
(HSP90) organizing protein (HOP), and protein phospha-
tase 5 (PP5) show an overall similar topology with the
TPRs of BUB1 and BUBR1 (3.6 A˚ average rmsd of Ca)Table 1. Crystal structures of BUB1 and BUBR1 domains reported
Structure Organism Construct length
Individual domains
N-terminal Bub1 S. cerevisiae 29-230
N-terminal BUBR1 Homo sapiens 57-220
C-terminal BUB1 H. sapiens 724-1085
Protein-peptide complexes
Bub3–GLEBS Bub1 S. cerevisiae 315-350 (Bub1); ful
Bub3–GLEBS Mad3 S. cerevisiae 353-395 (Mad3); fuldespite the low amino acid conservation in equivalent
positions (Figure 2B). Features characteristic of TPR
motifs and shared by Bub1 and BUBR1 include a concave
inner surface and right-handed super-helical twist of the
entire structure that results from the packing of a-helices.
Bub1 and BUBR1 TPR tandems also adopt a unique BUB
topology that is characterized by a shallow groove that is
defined by a loop insertion in TPR1, an insertion of a 310-
helix between TPR2 and TPR3, and non-canonical packing
interactions of TPR2. The significant reduction, but not
elimination, of the interaction with blinkin after site-spe-
cific substitution of residues located within the groove
suggests that kinetochore recruitment of BUB1 and
BUBR1 involves several potentially co-operative inter-
faces. Future work is required to define the precise nature
of these interactions and to establish whether the shallow
blinkin-binding groove confers a unique functionality to
N-terminal BUB1, BUBR1 or both.
The analysis of structurally related TPRs in complex
with their peptide ligands provides some clues in this
regard. Superposition of the crystal structures of the triple
TPR tandem of Bub1 (PDB3ESL) andBUBR1 (PDB 2WVI)
with the TPR1 domain of HOP in complex with a heat
shock cognate 70 (HSC70) peptide (PDB 1ELW); the
TPR2A domain of HOP in complex with a HSP90 peptide
(PDB 1elr) [16]; the PP5 TPR in complex with a HSP90
peptide (PDB 2BUG) [17] and the PEX5 TPR in complex
with a peroxisomal targeting signal-1 (PTS1) peptide (PDB
1FCH) [18] show that BUB1 and BUBR1 residues involved
in binding blinkin are mapped onto the TPR-formingto date
Resolution PDB code Refs
1.74 A˚ 3ESL [14]
1.80 A˚ 2WVI [15]
2.31 A˚ 3E7E [47]
l-length (Bub3) 1.90 A˚ 2I3S [31]
l-length (Bub3) 2.80 A˚ 2I3T [31]
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Figure 2. Structural understanding of BUB1 and BUBR1. (a) Superposition of the yeast (Sc) Bub1 TPR domain (red) and the human (Hs) BUBR1 TPR domain (yellow)
showing the distinctive features of the ‘‘BUB fold’’. (b) Superposition of HsPP5 TPR (cyan), HsHOP TPR1 (violet), HsHOP TPR2 (deep blue), HsPEX5 TPR (magenta), ScBub1
TPR (light blue), and HsBubR1 TPR (green) reveals a similar concave face. PEX5 binds PTS1 (yellow), and HOP TPR1 binds the HSC70 peptide GPTIEEV (red). The PP5 TPR
and HOP TPR bind the same pentapeptide sequence MEEVD (from HSP90, brown and black, respectively) in a different mode. In human TPR BUB1 and TPR BUBR1, residues
of the blinkin-binding region map onto a helices equivalent to those of PP5 TPR, HOP TPR, and PEX5 TPR that are engaged in peptide binding, thus suggesting a similar
binding mode. (c) Superposition of yeast BUB3–GLEBS complexes: Bub3 (magenta)–Mad3 GLEBS (deep blue) complex (PDB code: 2I3T), Bub3 (cyan)–Bub1 GLEBS (green)
complex (PDB code: 2I3S). (d) Salt bridges formed between residue E382 of Mad3 (in Bub1 the equivalent position is E337) and Bub3 R-197 and between E383 of Mad3
(equivalent residue E338 in Bub1) with Bub3 K152 contribute to stabilization of the interactions. (e) Cartoon representation of the BUB1 kinase domain. The N-terminal
extension and the P+1, activation and catalytic loops are highlighted. The magnesium ion is represented by the blue sphere. ATP, W742 (the residue that forms multiple
contacts with the activation segment), and G866 (which functions as the gatekeeper residue) are shown in sticks. (f) Superposition of a 3D model structure of the kinase
domain of BUBR1 and the crystal structure of BUB1 suggests the two domains exhibit high structural similarity.
Review Trends in Biochemical Sciences March 2011, Vol. 36, No. 3helices that are involved in protein–peptide interactions
(Figure 2B). Although the size of the protein–peptide
interface in these complexes, measured as the change in
solvent-accessible surface area buried on complex forma-
tion, is relatively small (HOP TPR–HSC70, 430 A˚2; HOP
TPR2–HSP90, 380 A˚2; and PP5 TPR-HSP90, 260 A˚2) and
therefore unlikely to give tight binding, additional residues
might contribute to the interactions in full-length proteins.
For example, the binding of the HSP90 MEEVD sequence
to HOP TPR2 induces a conformational change that seems144to expose further interaction areas within full-length HOP
[19]. It will be important to establish if similar gross
conformational changes might occur during the interaction
of blinkin with full-length BUB1 and/or BUBR1.
The KEN box, a protein motif defined by consecutive
lysine, glutamate, and asparagine residues, that often
mediates substrate recognition, is present in BUB1,
BUBR1 and Mad3 (Figure 1). Two KEN boxes located
in the N-terminal half of human BUB1 directly bind and
ensure efficient phosphorylation of CDC20 [20]. Deletion of
Review Trends in Biochemical Sciences March 2011, Vol. 36, No. 3either KEN box affects BUB1–CDC20 binding, whereas
deletion of both KEN boxes abolishes CDC20 binding.
Consequently, the two KEN boxes are required for
BUB1 ubiquitylation by APC/C–CDH1 [21] (CDH1 is
responsible for APC/C activity from late mitosis to the
G1–S transition). Flies that express BubR1 that harbors
alanine substitutions of two residues, K7 and E8, which
form part of the single N-terminal KEN box, exhibit a
normal spindle function, but a defectivemitotic checkpoint,
thus indicating that the N-terminal KEN box is crucial for
SAC function [22]. Although mouse BUBR1 contains one
CDC20 binding site between residues 490 and 560, muta-
tions that disrupt CDC20 binding to this region do not
affect checkpoint function [23]. This observation is in
conflict with a similar study based on truncated constructs
of mouse BUBR1, where it is suggested that both KEN
boxes are required for association with CDC20 [24]. How-
ever, an independent study based on the use of full-length
BUBR1 and peptides that mimic the two KEN box motifs
has shown that the N-terminal, but not the C-terminal
KEN-box interacts directly with CDC20. Similar features
have been observed in budding and fission yeast Mad3
[25–27], thus supporting the notion of BUBR1 acting as a
competitive inhibitor of substrate binding in a process that
is mediated by the interaction between the N-terminal
KEN box and CDC20. Biophysical studies of N-terminal
BUBR1 have demonstrated that the first BUBR1 KEN box
is located within a flexible region of low complexity that
extends from the TPR domain [15]. In addition to the low
conformational constraints in this region, which should
facilitate the presentation of the KEN box to APC/C–
CDC20, diverse post-translational modificationsmight pro-
vide an additional level of regulation. For instance, a phos-
phoproteome analysis of cultured cancer cells has identified
phosphorylation ofBUBR1residueT54 [28]. Althougha role
for T54 phosphorylation in mitosis remains to be estab-
lished, this residue lies at the boundary between the
N-terminal extension and the TPR domain [15]. This gives
rise to the possibility of local conformational changes that
affect the interaction of theKENbox and theAPC/C-CDC20
complex. Moreover, BUBR1 undergoes acetylation by the
histone acetyltransferase PCAF (p300/CBP-associated fac-
tor); K250 acetylation regulates APC/C-CDC20-mediated
pre-anaphase degradation of BUBR1, thus contributing to
themodulation of mitotic timing [29]. Given the importance
of the already-characterized BUBR1 post-translational
modifications, the identification and characterization of
other BUBR1 post-translational modifications and their
effects on the modulation of APC/C activity and mitotic
timing are of utmost importance.
BUB3 binding motif
Most of the residues that connect the N- and C-terminal
regions of BUB1, BUBR1 and Mad3 are predicted to be
mainly disordered. This region contains a conserved
stretch of about 40 amino acid residues that is identified
as the BUB3 binding site, and is commonly referred to as
the GLEBSmotif (residues 240–280 in human BUB1; 400–
440 in human BUBR1 and 360–400 in S. cerevisiaeMad3).
Overexpression of the GLEBS motif in HeLa cells causes
disruption of the SAC by competing with endogenousBUB1 and BUBR1 for binding BUB3 [30]. Similarly, muta-
tions that affect the GLEBS motif of human BUBR1 abol-
ish the interaction with BUB3, an interaction that is
essential for BUBR1 kinetochore localization [27]. The
BUB1 and BUBR1 GLEBS motifs exhibit high amino acid
sequence similarity with the GLEBS motifs of the human
and yeast nucleoporins, NUP98 and Nup116, respectively.
However, mouse BUB3 lacks affinity for the GLEBS motif
of human nucleoporin NUP98, which demonstrates that
the binding of SAC proteins to GLEBS motifs is highly
specific. BUB3 is a protein that is organized as a seven-
bladed b-propeller with a canonical WD40 repeat fold. The
crystal structures of two independent complexes formed
between yeast Bub3 and peptides that mimic the GLEBS
motifs of Mad3 and yeast Bub1 reveal some conserved
interactions (Figure 2C) [31], that is, a pattern of salt
bridges formed between Bub3 and two glutamate residues
of the GLEBS motifs (Figure 2D). In the two binary com-
plexes, the GLEBS peptides form an extensive interface
along the top surface of the b-propeller of Bub3. A single
amino acid substitution in the GLEBS motif and the top
face of Bub3 is sufficient to disrupt the protein interface,
thus leading to extensive defects in chromosome segrega-
tion. The GLEBS motif–Bub3 interaction involves a tran-
sition from a predominantly disordered (unbound) to a
more ordered (Bub3-bound) state. In view of the fact that
regions of low structural complexity can bind to a wide
variety of structurally distinct substrates, it will be inter-
esting to define the role in ligand binding, if any, of
conserved residues that surround the GLEBS motif.
Kinase domain
Protein phosphorylation and dephosphorylation are im-
portant regulatory mechanisms of SAC signaling [32,33].
Nevertheless, the requirement of BUB1 and BUBR1 ki-
nase activity in the mitotic checkpoint and in the stabili-
zation of correct kinetochore–microtubule attachments
remain contentious issues [24,30,34–40]. Some reports
have suggested that BUB1 catalytic activity is of para-
mount importance because BUB1-mediated CDC20 phos-
phorylation inhibits APC/C–CDC20 in human cells [20].
Moreover, BUB1 depletion or expression of a BUB1 kinase-
inactive mutant abolishes CDC20 phosphorylation and
suppresses the SAC [20]. Independent observations that
the BUB1 kinase-dead mutant is less effective in rescuing
the defect of BUB1 knockdown [22] lend further support to
the notion that BUB1 kinase activity is required for an
appropriate SAC response. However, other reports have
suggested that BUB1 kinase activity is of marginal rele-
vance in the establishment of mitotic arrest [5,13,38], but
instead, is important for chromosome alignment [13] and
centromeric localization of SGO1, a protein that acts as
protector of centromeric cohesion [41,42].
Phosphorylation and dephosphorylation of SAC compo-
nents involve a complex signaling cascade [32]. BUBR1
undergoes auto-phosphorylation when the SAC is unsatis-
fied and acts as the substrate of other kinases such as Polo-
like kinase 1 and cyclin-dependent kinase 1 (CDK1) [37,43].
Although some studies have shown that BUBR1 can inhibit
the APC/C even after introduction of site-specific or deletion
mutations that inactivate the kinase domain [44], others145
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process [34]. Similarly, BUBR1 kinase activity might be
important for efficient chromosome capture and congression
[36,45]; however, other reports have indicated that BUBR1
kinase inactivation has a minimal effect on chromosome
attachment [24,46]. Furthermore, prolonged mitotic arrest
is triggered by BUBR1 kinase activity and/or phosphoryla-
tion [24]. Chromosome congression delay and unstable
metaphase alignments have been observed in Drosophila
melanogaster that expresses a kinase-dead BubR1 mutant
(K1204A), thus indicating that BubR1 catalytic activity is
required for correct kinetochore–microtubule attachments
in flies [22]. Chromosome segregation is relatively unaffect-
ed in BubR1 kinase-dead mutant flies, which suggests that
BubR1 kinase activity is substantially more important for
spindle assembly than it is for the SAC.
Plausible explanations for the conflicting data on the
role of the BUB1 and BUBR1 kinases in the SAC include
intrinsic variations due to different assays used for meas-
urement of SAC response and/or different efficiencies of
depleting the endogenous protein [22]. In addition, the
importance of kinase activity of mitotic checkpoint kinases
might depend on the underlying genetic background and
its inherent defects [13,32].
Although the role of BUB1 kinase activity in the SAC
remains uncertain, clues about human BUB1 kinase regu-
lation are provided by the crystal structure of its C-termi-
nal region, which reveals a typical kinase fold (residues
784–1085) and anN-terminal extension (residues 724–783)
that is highly conserved among BUB1 proteins and wraps
around the kinase N lobe (Figure 2E). A particularly
interesting feature is the interaction of the N-terminal
extension with the kinase domain, which resembles the
mechanism of activation of CDKs by cyclins. Although the
crystal structure suggests a kinase in its active conforma-
tion, the C-terminal half of the P+1 loop adopts a hairpin-
like structure that hides the catalytic loop, thus limiting
access of ATP [47]. Such conformational features suggest
that the structural reorganization of the C-terminal half of
the P+1 loop (residues 965–972) is required for the efficient
phosphorylation of BUB1 substrates.
A 3D model structure of C-terminal BUBR1 (residues
764–1044) shows the canonical features of a protein kinase:Table 2. Human BUB1 amino acid substitutions associated with c
BUB1 region Residue Domain
N-terminal E36!D TPR doma
Deletion 76-141,
frameshift
A130!S
140, transition of the
splicing donor site
R209!Q
G250!N GLEBS mo
Y259!C
H265!N
Middle S375!F Low comp
S492!Y
K566!R
P648!R
C-terminal 827 Deletion, frameshift Kinase do
S950!G
aThese authors incorrectly number these residues; the numbering show here is correc
146an N-terminal lobe that consists of a series of antiparallel
b-sheets and a conserved a-helix, and a C-terminal lobe
that is predominantly helical. A cavity located between the
two lobes defines the ATP binding site. Superposition of a
3D model structure of BUBR1 kinase generated by com-
parative modelling using the crystal structure of BUB1
kinase as a template suggests that the two kinases adopt a
very similar structure (Figure 2F). It is important to
confirm this prediction and to determine whether an equiv-
alent N-terminal extension that wraps around the kinase
N lobe to modify the catalytic activity exists in BUBR1.
BUB1 and BUBR1 mutations in cancer
Aneuploidy is a common characteristic among cancer cells.
Deletions, insertions and point and silent mutations asso-
ciated with aneuploidy, chromosome instability and cancer
occur throughout theBUB1 andBUBR1 sequences (Tables
2 and 3). A role for BUB1 in oncogenesis is indicated by the
occurrence of BUB1 mutations, differential BUB1 gene
and protein expression in cancer tissues and cell lines,
and the formation of spontaneous cancers in mice that
express hypomorphic alleles [48–58]. BUBR1 truncating
and missense mutations have been identified in families
with mosaic-variegated aneuploidy (MVA), a syndrome
that is characterized by microcephaly and growth and
mental retardation [40,59]. These biallelic mutations have
provided new clues about cancer development; they are the
first to relate germline mutations in a spindle checkpoint
gene with a human disorder. Genetic testing has suggested
that a decrease of >50% in BUBR1 expression (or activity)
accounts for premature chromatid separation (PCS) syn-
drome in a cohort of Japanese families with monoallelic
BUBR1 mutations [60]. Moreover, aneuploidy and gastric
cancer progression are known outcomes of BUBR1 over-
expression [61,62]. Importantly, it might be possible to use
BUBR1 expression as a marker of poor survival in certain
types of human cancer [62,63].
Structural information allows the mapping onto the
protein surface of some of theBUB1 andBUBR1mutations
that have been associatedwith chromosome instability and
cancer progression. BUB1 residue A130 is exposed on the
surface and lies in a region that connects the a-helices of
the TPR units [14]. A substitution of this residue to serineancer
Clinical condition Refs
in Colorectal cancer [49]
Colorectal cancer [48]
Lymph node metastasis [53]
Colorectal cancer [48]
Lung cancer [57]
tif region ATLL [67]a
Pancreatic cancer [54]
Pancreatic cancer [54]
lexity region Colorectal cancer [68]
Colorectal cancer [48]
Colorectal cancer [68]
Colorectal cancer [49]
main Thyroid follicular
adenoma
[56]
Colorectal cancer [69]
t.
Table 3. Human BUBR1 amino acid substitutions associated with cancer
BUBR1 region Residue Domain Clinical condition Refs
N-terminal M40!T KEN box region Colorectal cancer [48]
Y155!C TPR domain MVA [40]
E166!D ATLL [67]a
R224!, nonsense PCS syndrome [60]
A302!P Low complexity region ATLL [67]
Q/A349!A/Q Glioblastomas, breast cancer,
colorectal cancer
[49,68]
Q!R Glioblastomas [70]
Q363!R Identified in breast cancer cell lines [71]
E390!D Close to the GLEBS
motif region
Wilms tumor [72]
Middle 523-538, deletion Low complexity region ATLL [67]
R550!Q Microcephaly, eye abnormality, MVA [40,73]
X612 Deletion,
frameshift
PCS syndrome [60]
V618!A Colorectal cancer [74]
R727!C MVA [40]
738, insertion,
frameshift
MVA [59]
C-terminal R814!H Kinase domain MVA [40,59]
L844!F Cryptorchidism [40,75]
I909!T Cerebellar hypoplasia, MVA [40,73]
Q921!H No observable effects [40,59]
S928!nonsense B-cell lymphoma [67]
L1012!P Hypothyroidism, anemia [40,59]
1023, deletion Colorectal cancer [48]
L1031!Q ATLL [67]
aThese authors incorrectly number these residues; the numbering show here is correct.
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and is predicted to disrupt stabilizing interactions between
TPR-forming a-helices [14]. Recent evidence has shown
that the A130Smutant impairs the localization of BUB1 at
kinetochores, increases the rate of congression errors, and
causes the loss of kinetochore binding of BUBR1, CENP-F
and SGO1 [13]. The BUB1 H151D substitution probably
has a similar impact on the structure, whereas the deletion
mutant D76-141 should lead to a considerable disturbance
of the entire TPR-containing domain structure [14]. The
BUB1 substitution R209Q is mapped immediately after
the TPR domain and onto a region that is predicted to be of
low structural complexity. The effect of the R209Q substi-
tution on the structure of BUB1 remains unknown. Quan-
titative immunofluorescence studies of two BUB1
substitutions, Y259C and H265N, which lie in close prox-
imity to the BUB3-binding domain [53,54], show kineto-
chore localization and expression at levels comparable to
native BUB1. The H265N substitution shows a normal
chromosome alignment and spindle checkpoint and is able
to recruit BUBR1, MAD1 and MAD2 to kinetochores in
cells depleted of endogenous BUB1 [13]. By contrast, the
BUB1 Y259C substitution does not rescue the spindle
checkpoint. However, it efficiently restores chromosome
congression and rescues the ability of kinetochores to bind
SGO1 and CENP-F [13]. Further work is needed to clarify
the mechanism of action of these mutations. Nearly 50% of
the BUB1 substitutions associated with cancer can be
mapped onto regions that are predicted to be mostly disor-
dered (Table 2), thereby opening the possibility that sub-
stitution of these residues impairs protein–protein
interactions.
Several cancer-associatedmutations are found through-
out the human BUBR1 sequence. The Y155C mutant ismapped onto the third TPR repeat of the blinkin-binding
domain. Y155C and R224 nonsense substitutions are as-
sociated with MVA and PCS syndrome, respectively. The
E166D mutant, which has been identified in adult T-cell
leukaemia/lymphoma (ATLL) patients, is mapped onto the
loop region that connects a-helices A and B of the third
TPR repeat. BUBR1 residue E166 is surface-exposed and
highly conserved across species, which suggests a function-
al role. Interestingly, the majority of BUBR1 mutations
that are associated with different classes of cancer can be
mapped onto regions of predicted low structural complexi-
ty (Table 3). Those mapped onto the kinase domain are the
second most frequent, followed by those located in the
blinkin-binding domain (Table 3). Several cancer-related
mutants can be mapped onto the 3Dmodel structure of the
BUBR1 C terminus (residues 764–1044) (Figure 2F). The
L844F mutant maps onto a helix aD; Q921H and S928
nonsense substitutions are located in the substrate-bind-
ing P+1 loop, and R814H maps onto the aC helix; a region
that in BUB1 (and possibly BUBR1) enables ATP binding
by neighboring residues [47]. Residue I909 is mapped
immediately upstream of the magnesium-binding loop,
whereas residues L1012 and L1031 map onto a helices
aG and aH, respectively. Deletion of residues 1024–1050
is associated with colorectal cancer and results in a trun-
cated protein that lacks a helices aH and aI. Substitution
of L1012 by proline, which has been linked to hypothy-
roidismandanemia rather than cancer [40,59], is expected
to affect the conformation of aG helix through the inser-
tion of a kink at this position. Compared toBUB1, a larger
number of BUBR1mutations associated with cancer have
been reported to date. As noted above for BUB1, nearly
half of the cancer-associated substitutions are mapped
onto regions that are predicted to be of low structural147
Box 2. A model of BUB1 and BUBR1 (Mad3) interactions in the SAC
The 3D structural information of different SAC components provides
clues to the function of the SAC. First, when the SAC is unsatisfied,
BUB1 and BUBR1 are recruited to unattached or incorrectly attached
kinetochores through the formation of a ternary complex with blinkin
(Figure I). The BUB1 KEN boxes mediate BUB1 degradation by the
APC/C–CDH1 in the G1 phase of the cell cycle and BUB1–CDC20
binding. Phosphorylation of CDC20 S153 by BUB1 is required for
efficient SAC activity. The BUBR1 and BUB1 TPR domains each bind
blinkin, whereas their C-terminal regions mediate interactions with
each other and with BUB3 through the GLEBS motif. Binding to the
kinetochore stimulates BUBR1 kinase activity, which results in
prolonged mitotic arrest. CENP-E-dependent inhibition of BUBR1
kinase activity probably leads to microtubule attachment that over-
comes the mitotic arrest. Second, direct interactions between the
BUBR1 KEN boxes and CDC20, when BUBR1 forms part of the MCC,
results in the inhibition of APC/C–CDC20 ubiquitin ligase activity. One
potential mechanism by which BUBR1 kinetochore recruitment
induces prolonged APC/C–CDC20 inhibition posits the existence of a
signaling cascade whose downstream targets include enzymes that
post-translationally modify BUBR1 (including acetylation of residue
K250 by PCAF), thus affecting its interaction with and inhibition of
APC/C–CDC20. Alternatively, kinetochore recruitment might induce
conformational changes in BUBR1 thereby enabling subsequent
APC/C inhibition.
[(Box_2)TD$FIG]
Figure I. BUB1 and BUBR1 exert functions in the SAC through a range of protein–protein interactions.
Review Trends in Biochemical Sciences March 2011, Vol. 36, No. 3complexity. It is particularly interesting to note that all
the BUBR1 substitutions located adjacent to or within the
kinase domain result in a severe decrease of protein
concentration, probably reflecting an effect on protein
stability [40]. In fact, the diverse substitutions mapped
onto this region should affect protein stability to a differ-
ent extent, thus resulting in a distinct decrease of
BUBR1 concentration, a scenario that is consistent with
the observed dependence of the amount of chromosome
segregation defects on BUBR1 concentration in the cell
[40]. Although studies onBUB1andBUBR1mutants have
suggested that cancer formation is linked to a weakened
SAC, the precise roles of thesemutants in tumor formation
remain unclear.
Changes in expression profiles of BUB1 and BUBR1 are
often encountered in cancer cells and result in the im-
pairment of mitotic checkpoint function. The observation
that the weakening of the SAC provides an advantage for
cell survival suggests that targeting the SAC might be a148fruitful strategy for clinical anticancer therapies [64,65].
The crystal structure of the N-terminal domain of Bub1
reveals a hydrophobic pocket that binds CHES (2-[n-cyclo-
hexylamino]ethane sulfonic acid), a compound of low mo-
lecular mass; this could be a useful site to target in drug
discovery. The kinase N lobe, which is important for the
regulation of BUB1 catalytic activity, binds the small
molecule 2OH-BNPP1 (2-({4-amino-1-tert-butyl-1H-pyra-
zolo[3,4-d]pyrimidin-3- yl}methyl)phenol) in the ATP pock-
et with high specificity, and inhibits its activity. Hence,
2OH-BNPP1 and related molecules could constitute novel
chemical toolkits for the study of BUB1 function in vivo and
in vitro. More recent work has shown that pharicin A, a
natural diterpenoid, which might act as an ATP-competi-
tive inhibitor [66], can induce mitotic arrest of paclitaxel-
sensitive and -resistant tumor cells through the inhibition
of BUBR1 activity [66].Whether thesemolecules can assist
the design of compounds of potential therapeutic interest
remains to be seen.
Review Trends in Biochemical Sciences March 2011, Vol. 36, No. 3Concluding remarks
The engagement of BUB1 and BUBR1 (Mad3) in multiple
protein–protein interactions highlights their remarkable
plasticity. The emerging structural details of BUB1 and
BUBR1 (Mad3) provide a foundation for defining their
functions in theSAC (Box2); thesedetailsprovidemolecular
insight into the recognition mechanism that mediates their
localization to the kinetochore and the role of the amino acid
residue substitutions thathavebeenassociatedwith cancer.
Furthermore, given the potential benefit of targeting the
SAC as a novel approach in anticancer therapy, the BUB1
and BUBR1 structures should be important in structure-
guided drug design and the development of animal models
that harbor cancer-derived mutations. Future work could
aim to differentiate further the roles of the various domains
and cellular pools of BUB1 and BUBR1 (Mad3) in the SAC
and to elucidate the molecular mechanisms that mediate
communication between the mitotic checkpoint pathway
with the kinetochore–microtubule network and the DNA
repair machinery. Atomic-resolution structures of most of
the SAC protein components (alone and as part of macro-
molecular assemblies) should provide molecular insights
into the mechanisms of regulation of the SAC and an
understanding of how the spindle checkpoint translates
the imbalance of force at the kinetochores into an APC/C-
inhibitory signal.
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